Dr. Bennett at the University of South Carolina School of Medicine is conducting a study into Fluoroquinolone (FQ) genetic predispositions.
Could Fluoroquinolone induced brain fog actually be "Chemobrain," a late effect experienced by those who have systemic chemotherapy? Join me as we take a look a this interesting topic.
Is it possible to be floxed by Fluoroquinolone eye drops? Join me as we briefly look at the data to answer this sometimes controversial question.
I have found, more often than not, that the FQ data trail leads us into areas where we do not want to go; areas that we would normally avoid, if it were up to us. Areas that are ugly inconvenient truths.
Using fluoroquinolones increase a patients risk of suffering serious, potentially permanent, and delayed onset nerve damage by almost 50 percent.
Cipro 28,000 Deaths and Counting...
Levaquin 26,000 Deaths and Counting...
June 28, 2019, the FDA updated the Levaquin label MEDICATION GUIDE which is the information given to patients.
Dr. Bennett and Southern Network For Adverse Reactions (SONAR) have submitted another Citizen Petition to the FDA requesting new Fluoroquinolone Black Box Warning.
Could hydrogen sulfide (H2S) be driving some of your chronic floxing symptoms? Evidently it is in a subset of individuals who are chronically floxed.
This article is part one is a series exploring the history of fluoroquinolone antibiotics viewed from a unique perspective trying to uncover insights on their propensity for harm.
For each chronic FQAD sufferer there is a fine line between validation, true hope, and those commonly seen sanitized stories or messages that border on toxic positivity. One Chronic FQAD sufferer candidly shares her struggles.
Dr. Jack Kruse's ideas on the mechanisms of Fluoroquinolone Toxicity. This is an above average read for many, but some great ideas can be gleaned from it.
Recently I did an interview with WebMD author/reporter Matt McMillen on the dangers of Fluoroquinolones.
The separate “Psychiatric Adverse Events” section was FINALLY added to the Levaquin label and it includes the additional psychiatric adverse events.